Bethany Hannafon to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Bethany Hannafon has written about Xenograft Model Antitumor Assays.
Connection Strength
0.454
-
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer. J Pharmacol Exp Ther. 2025 Jan; 392(1):100004.
Score: 0.223
-
miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study. BMC Cancer. 2019 Jun 28; 19(1):642.
Score: 0.153
-
Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1. BMC Cancer. 2018 Oct 26; 18(1):1042.
Score: 0.037
-
Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1) degradation. J Nutr Biochem. 2014 May; 25(5):515-25.
Score: 0.026
-
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists. Invest New Drugs. 2005 Oct; 23(5):417-28.
Score: 0.015